Solihull Health Check Clinic has officially rebranded its medical cannabis service as Airmed Clinic, marking a new chapter in affordable and patient-focused care.
Working in collaboration with The VOR Group, Airmed Clinic has introduced a more competitive pricing structure, expanded its prescriber team, and enhanced its clinical governance framework to support a wider range of conditions.
The rebrand reflects Airmed’s mission to deliver high-quality patient care while improving access to treatment for those who need it most.
Strengthening access through My Dispensary
Airmed has entered a strategic partnership with My Dispensary, the UK’s most advanced medical cannabis pharmacy platform. This integration provides patients with:
- Real-time stock visibility – prescribers can instantly view available products, reducing delays from prescription rewrites.
- Streamlined prescription processing – ensuring faster access to medication. • Transparent pricing – helping to make treatments more affordable. • Future patient-reported outcomes data – giving prescribers valuable insights to support better-informed treatment decisions.
Launching MYPAS: The My Patient Access Scheme
Alongside this partnership, MyDispensary is launching MYPAS (My Patient Access Scheme) – a programme designed to support low-income patients while collecting valuable clinical data to advance the understanding of medical cannabis.
MYPAS offers free clinic consultations and ongoing medication discounts for eligible groups:
- Free Clinic + 18% Off – Supporting patients on government assistance. • Free Clinic + 12% Off – Available to students and pensioners.
- Free Clinic + 6% Off – For veterans, NHS staff, emergency responders, frontline workers, and professionals in the medical cannabis and wellness industry.
Expanding clinical expertise
Airmed Clinic has expanded its prescriber team to meet rising demand, offering patients access to a broader range of clinical expertise. This ensures timely consultations, personalised treatment plans, and greater appointment flexibility, all while lowering the costs of care.
Pat Fegan, Clinical Lead at Airmed Clinic, said:
“Rebranding to Airmed Clinic is more than a name change, it’s about modernising our service and expanding our capability to ensure we are able to compete in a fast evolving market. Through our partnership with My Dispensary our patients will have access to an innovative product platform and access scheme to optimise the experience and reduce delays and associated costs, which means we can deliver care in a way that truly puts patients first.”
Liam McGreevy, CEO of The VOR Group, added:
“Our goal has always been to make treatment pathways more sustainable and accessible. By integrating Airmed with My Dispensary’s real-time stock platform we offer their patients a guarantee of delivery of their prescription, and unique features to optimise the prescription management process. With the launch of MyPAS, we’re tackling two critical issues at once, reducing barriers to care for those who struggle to access treatment currently, while building meaningful clinical data for the future.”
